In glioma cells, cell invasion was inhibited by BMAL1 overexpression through blocking of PI3K/AKT/matrix metalloproteinase-2 (MMP2) pathway where BMAL1 attenuates BCL-W oncogene that activates the invasion pathway (89). This evidence concerns the gene MMP2 and central nervous system cancer.